Clinical efficacy, safety and mechanism of Yiqi Shengjin powder on blood pressure in patients with abnormal glucose metabolism and hypertensio
- Conditions
- abnormal glucose metabolism and hypertension
- Registration Number
- ITMCTR2200006446
- Lead Sponsor
- Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- Not specified
1) The subject or responsible guardian shall sign the informed consent; 2) Aged 18-75 years; 3) In patients with impaired fasting glucose, abnormal glucose tolerance or type 2 diabetes mellitus(HbA1C<8% in the past 2 weeks without taking or taking western antidiabetic drugs); 4) Patients with grade 1-2 essential hypertension; 5) TCM syndromes accord with Qi and Yin deficiency syndrome
1) Pregnant and lactation patients;
2) Malignant tumors or blood diseases;
3) Patients who are critically ill or not yet stable in the acute phase, have consciousness disorders, severe cognitive dysfunction or serious mental diseases;
4) A history of alcohol and drug abuse;
5) Patients with acute myocardial infarction, unstable angina pectoris, large aneurysm or dissecting aneurysm, NYHA class III-IV heart failure, malignant arrhythmia, and other severe liver, kidney, hematologic, cerebrovascular diseases and severe osteoporosis within 6 months (Note: Liver dysfunction is to point to alanine aminotransferase or aspartate aminotransferase value is greater than 2 times the upper limit of normal; Renal insufficiency refers to a serum creatinine value greater than 2 times the upper limit of normal);
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method